-

Westaim Announces Closing of Skyward Specialty’s Secondary Offering

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES.

TORONTO--(BUSINESS WIRE)--The Westaim Corporation (“Westaim” or the “Company”) (TSXV: WED) announces the closing of the previously announced Skyward Specialty Insurance Group, Inc.™ (NASDAQ: SKWD) (“Skyward Specialty”) secondary public offering (the “Offering”). Under the Offering, Westaim, through its wholly-owned subsidiary, Westaim HIIG GP Inc. (the “Selling Stockholder” or “Subsidiary”), sold 5,060,000 shares of the common stock of Skyward Specialty (the “Shares”) (which included the exercise in full of the underwriters’ over-allotment option) at a price to the public of US$36.50 per Share. The proceeds to the Selling Stockholder, less underwriting commissions, were approximately US$177.3 million. The Company now holds a 4.8% interest in Skyward Specialty through the Subsidiary.

Barclays, Keefe, Bruyette & Woods, Inc., A Stifel Company, and Jefferies acted as joint lead book-running managers for the Offering. Citizens JMP, Piper Sandler & Co., Raymond James & Associates, Inc., Truist Securities, Inc., William Blair, TD Securities and Wolfe | Nomura Alliance acted as joint book-running managers for the Offering.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of the Shares in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About Westaim

Westaim is a Canadian investment company specializing in providing long-term capital to businesses operating primarily within the global financial services industry. The Company invests, directly and indirectly, through acquisitions, joint ventures and other arrangements, with the objective of providing its shareholders with capital appreciation and real wealth preservation. Westaim’s strategy is to pursue investment opportunities with a focus towards the financial services industry and grow shareholder value over the long term. Westaim’s investments include significant interests in Arena and the Arena FINCOs. Arena and Arena FINCOs are defined in the notes to Westaim’s audited consolidated financial statements for the year ended December 31, 2023 and the related MD&A. The common shares of Westaim are listed on the TSX Venture Exchange (the “TSXV”) under the trading symbol “WED”.

For more information, contact:
J. Cameron MacDonald, President and Chief Executive Officer or
Robert T. Kittel, Chief Operating Officer
The Westaim Corporation
info@westaim.com
(416) 969-3333

Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the Exchange) accepts responsibility for the adequacy or accuracy of this release.

Contacts

J. Cameron MacDonald, President and Chief Executive Officer or
Robert T. Kittel, Chief Operating Officer
The Westaim Corporation
info@westaim.com
(416) 969-3333

The Westaim Corporation

TSX VENTURE:WED

Release Summary
Westaim announces closing of Skyward Specialty’s secondary offering
Release Versions

Contacts

J. Cameron MacDonald, President and Chief Executive Officer or
Robert T. Kittel, Chief Operating Officer
The Westaim Corporation
info@westaim.com
(416) 969-3333

More News From The Westaim Corporation

The Westaim Corporation Announces Grants of Security-Based Compensation and Amendment to Long-Term Equity Incentive Plan

TORONTO--(BUSINESS WIRE)--The Westaim Corporation (“Westaim” or the “Company”) announces that it has granted an aggregate of 1,578,258 stock options (the “Options”) and 124,812 restricted share units (the “RSUs”) under the Company’s long-term equity incentive plan (as amended and restated, the “LTIP”). The Options were granted to certain officers of the Company’s affiliate, Ceres Life Insurance Company (“Ceres Life”), and the RSUs were granted to an officer of Ceres Life. The Options have an ex...

The Westaim Corporation Announces Normal Course Issuer Bid

TORONTO--(BUSINESS WIRE)--The Westaim Corporation (“Westaim” or the “Company”) (TSXV: WED) is pleased to announce that the TSX Venture Exchange (the “Exchange” or “TSXV”) has accepted a notice (the “Notice”) filed by the Company of its intention to make a normal course issuer bid (the “NCIB”). In connection with the NCIB, the Company entered into an automatic share purchase plan (an “ASPP”) with TD Securities Inc. (“TD”) to allow for purchases of its common shares (the “Shares”). In connection...

Westaim Reports Q3 2025 Results for the Quarter Ended September 30, 2025

NEW YORK--(BUSINESS WIRE)--The Westaim Corporation (“Westaim” or the “Company”) (TSXV: WED) today announces its unaudited interim financial results for the quarter ended September 30, 2025. Westaim recorded a net loss attributable to controlling interests of $11.7 million ($0.35 diluted loss per share) for Q3 2025 compared to a net loss of $1.2 million ($0.05 diluted earnings per share) for Q3 2024. “Westaim continued to develop its integrated asset management and insurance platform during the...
Back to Newsroom